scotin Activators
Scotin activators arechemical compounds that, either through direct or indirect interactions, can enhance the functional activity of scotin. Compounds that inhibit protein kinases, such as Staurosporine, can enhance scotin's functional activity by preventing its phosphorylation and subsequent degradation. Additionally, compounds that inhibit specific kinases involved in the ERK signaling pathway, such as Sorafenib and PLX4720, can indirectly enhance scotin activity by affecting this pathway.
Lastly, this group includes inhibitors of Bcl-2 family proteins, which are known to interact with scotin and can inhibit its pro-apoptotic activity. These include BH3I-1, ABT-737, Navitoclax, Obatoclax, and Venetoclax. By inhibiting Bcl-2 proteins, these compounds can enhance the functional activity of scotin by removing these inhibitory influences. S63845, a selective MCL1 inhibitor, also falls into this category, as MCL1 is a member of the Bcl-2 family and its inhibition can lead to an enhancement of scotin's functional activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, including PKC, which is known to mediate the phosphorylation of scotin. The inhibition of PKC by Staurosporine can enhance the functional activity of scotin by preventing its phosphorylation and subsequent degradation, thus leading to its increased presence and activity. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib is a multi-kinase inhibitor that also inhibits RAF kinase. RAF is part of the ERK signaling pathway, which can influence scotin activity. Inhibition of RAF by Sorafenib could enhance the functional activity of scotin indirectly through its effects on the ERK pathway. | ||||||
ABT 737 | 852808-04-9 | sc-207242 | 2.5 mg | $204.00 | 54 | |
ABT-737 is a Bcl-2 family protein inhibitor. It could enhance scotin's pro-apoptotic activity by reducing the inhibitory influence of Bcl-2 proteins on scotin. | ||||||
ABT 263 | 923564-51-6 | sc-207241 | 5 mg | $245.00 | 16 | |
Navitoclax is a Bcl-2 family protein inhibitor. By inhibiting Bcl-2 proteins, Navitoclax could enhance the functional activity of scotin by removing the inhibitory influence of Bcl-2 proteins. | ||||||
Obatoclax Mesylate | 803712-79-0 | sc-364221 sc-364221A | 5 mg 10 mg | $96.00 $141.00 | ||
Obatoclax is a pan-Bcl-2 inhibitor, which can enhance scotin's pro-apoptotic activity by reducing the inhibitory influence of Bcl-2 proteins. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $118.00 $337.00 $520.00 $832.00 $1632.00 | 10 | |
ABT-199 is a Bcl-2 inhibitor and can remove the inhibitory influence of Bcl-2 proteins on scotin, thus enhancing its functional activity. | ||||||
S63845 | 1799633-27-4 | sc-507518 | 1 mg | $150.00 | ||
S63845 is a selective MCL1 inhibitor. MCL1 is a Bcl-2 family protein that can inhibit the pro-apoptotic activity of scotin. Inhibition by S63845 could therefore enhance scotin's functional activity by removing this inhibitory influence. | ||||||